# VELOXIS PHARMACEUTICALS A/S

**CVR:** 26527767
**Status:** active
**Company type:** Aktieselskab
**Founded:** 2002-03-21
**Industry:** 721000, Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
**Address:** c/o Bech-Bruun, Gdanskgade 18, 2150 Nordhavn
**Employees:** 1 (1)
**Capital:** 686,400,000 DKK
**Website:** www.veloxis.com

> **Pro tier:** CDS credit-health score (0–100) for this company is available on Pro. Upgrade: https://companydata.dk/priser

## Financials


| Year | Revenue | Profit | Equity | Assets | Employees |

|------|---------|--------|--------|--------|-----------|

| 2026 | - | -1,553,000 DKK | 611,587,000 DKK | 612,939,000 DKK | 1 |

> **Pro tier:** 10 additional years of financial statements (2014–2025) available on Pro — including full revenue, profit, equity, and assets per year. Upgrade: https://companydata.dk/priser

## Owners (1)


- **Asahi Kasei Corporation**, ANDEN_DELTAGER, 1% ownership, since 2021-01-04

## Board of directors (34)


- **Kim Bjørnstrup**, FORMAND, since 2011-04-12
- **Kurt Anker Nielsen**, BESTYRELSESMEDLEM, since 2006-09-07
- **Jan-Erik Gunnar Svensson**, FORMAND, since 2002-03-21
- **Klaus Søgaard**, BESTYRELSESMEDLEM, since 2002-03-21
- **Claus Tycho Bræstrup**, FORMAND, since 2006-09-07
- **Troels Elkiær Andersen**, BESTYRELSESMEDLEM, since 2002-03-21
- **Mette Kirstine Agger**, BESTYRELSESMEDLEM, since 2010-04-21
- **Mette Kirstine Agger**, FORMAND, since 2015-03-26
- **Mette Kirstine Agger**, NÆSTFORMAND, since 2016-04-06
- **Anders Götzsche**, BESTYRELSESMEDLEM, since 2008-04-24
- **Florian Schønharting**, BESTYRELSESMEDLEM, since 2002-06-06
- **Ole Vahlgren**, BESTYRELSESMEDLEM, since 2002-06-06
- **Thomas Peter Dyrberg**, BESTYRELSESMEDLEM, since 2016-04-06
- **Thomas Peter Dyrberg**, NÆSTFORMAND, since 2009-08-31
- **Anders Buur**, BESTYRELSESMEDLEM, since 2002-06-06
- **Lars Kåre Viksmoen**, BESTYRELSESMEDLEM, since 2016-07-26
- **Flemming Ørnskov**, FORMAND, since 2005-09-21
- **Jean Joachim Deleage**, BESTYRELSESMEDLEM, since 2005-06-20
- **Gaston Georges Gerard Soula**, BESTYRELSESMEDLEM, since 2005-11-07
- **Paul Edick**, FORMAND, since 2009-04-23
- **Edward Etienne Penhoet**, BESTYRELSESMEDLEM, since 2011-07-07
- **Michael Thomas Heffernan**, BESTYRELSESMEDLEM, since 2015-03-26
- **Michael Thomas Heffernan**, FORMAND, since 2016-04-06
- **Robert Samuel Radie**, BESTYRELSESMEDLEM, since 2016-07-26
- **Paul Kevin Wotton**, BESTYRELSESMEDLEM, since 2016-07-26
- **Daisuke Matsuo**, BESTYRELSESMEDLEM, since 2020-02-17
- **Matthew Ryan Dumont**, BESTYRELSESMEDLEM, since 2020-02-17
- **Masaya Etoh**, BESTYRELSESMEDLEM, since 2020-02-17
- **Masaya Etoh**, FORMAND, since 2020-03-10
- **Hiroki Ideguchi**, BESTYRELSESMEDLEM, since 2021-04-14
- **Hideo Hikami**, FORMAND, since 2021-04-14
- **Yusuke Hiramatsu**, BESTYRELSESMEDLEM, since 2022-08-31
- **Keigo Nakatsukasa**, FORMAND, since 2023-05-22
- **Kenro Yuzaki**, BESTYRELSESMEDLEM, since 2025-09-04

## Executive management (18)


- **Hans Christian Eberhard Groth Teisen**, økonomidirektør, since 2008-02-29
- **Klaus Søgaard**, DIREKTØR, since 2002-03-21
- **Michael Wolff Jensen**, DIREKTØR, since 2003-08-01
- **Jan Møller Mikkelsen**, ADM. DIR., since 2003-01-01
- **Karin Jexner Hamberg**, DIREKTØR, since 2008-09-22
- **Johnny Stilou**, økonomidirektør, since 2012-05-23
- **Tomas Norling**, DIREKTØR, since 2002-06-06
- **Flemming Ørnskov**, ADM. DIR., since 2006-09-07
- **Peter Gudmund Nielsen**, DIREKTØR, since 2008-04-24
- **William James Polvino**, ADM. DIR., since 2009-12-02
- **Michael Beckert**, DIREKTØR, since 2008-04-24
- **James Stewart New**, ADM. DIR., since 2008-10-21
- **Craig Alexander Collard**, ADM. DIR., since 2015-12-10
- **Alastair Stuart McEwan**, DIREKTØR, since 2016-02-29
- **Morten Marott**, DIREKTØR, since 2018-04-03
- **Ira Duarte**, DIREKTØR, since 2018-10-31
- **Daisuke Matsuo**, ADM. DIR., since 2024-10-09
- **Mark Earl Hensley**, ADM. DIR., since 2021-11-08

## Secondary names

- LIFECYCLE PHARMA A/S

## Contact


- Website: www.veloxis.com

> **Pro tier:** Phone and email are available to logged-in users; detailed contact scraping is a Pro feature. Upgrade: https://companydata.dk/priser

---
*Free-tier view. Pro subscribers additionally see: 10 additional years of financial statements (2014–2025) available on Pro — including full revenue, profit, equity, and assets per year. CDS credit-health score (0–100) for this company is available on Pro. Phone and email are available to logged-in users; detailed contact scraping is a Pro feature. See https://companydata.dk/priser*

Source: Danish public registries (CVR / Ejendomsvurderingen). Canonical: https://companydata.dk/da/virksomhed/26527767-veloxis-pharmaceuticals-a-s